I.Ceram Overview

  • Founded
  • 2005

Founded
  • Status
  • Public

  • Employees
  • 18

Employees
  • Stock Symbol
  • ALICR

Stock Symbol
  • Investments
  • 1

  • Share Price
  • $11.02

  • (As of Thursday Closing)

I.Ceram General Information

Description

I.Ceram is a France-based company which designs, manufactures and markets high-tech implants for various joints of the human body. The company manufactures implants for ankle, hip, shoulder, wrist, skull, foot, and spine.

Contact Information

Website
www.iceram.fr
Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Therapeutic Devices
Stock Exchange
PAR
Primary Office
  • 1 rue Columbia
  • Parc d'Ester Technopole
  • 87280 Limoges
  • France
+33 05 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

I.Ceram Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$11.02 $10.94 $10.27 - $30.43 $3.22M 292K 103.25 -$0.15

I.Ceram Financials Summary

In Thousands,
USD
TTM 31-Dec-2021 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 7,123 7,123 12,050 14,442
Revenue 2,542 2,542 2,203 2,051
EBITDA (107) (107) (931) (2,330)
Net Income (913) (913) (1,741) (3,095)
Total Assets 6,132 6,132 7,025 7,392
Total Debt 2,591 2,591 1,837 1,423
Public Fundamental Data provided by Morningstar, Inc. disclaimer

I.Ceram Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore I.Ceram‘s full profile, request access.

Request a free trial

I.Ceram Patents

I.Ceram Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3120512-A1 Sternal reconstruction interface Pending 12-Mar-2021 00000000000 0
EP-3771474-A1 Material for capturing cells circulating in blood, method for preparing same and use thereof Pending 01-Aug-2019 0000000000 0
FR-3099373-A1 Material for capturing circulating cells in the blood, method of preparation and use Pending 01-Aug-2019 0000000000 0
US-20210032626-A1 Material for capturing circulating cells in the blood, method of preparation and use Pending 01-Aug-2019 0000000000
US-11357638-B2 Prosthetic ankle with a flat section Active 17-May-2018 A61F2/4202 0
To view I.Ceram’s complete patent history, request access »

I.Ceram Executive Team (3)

Name Title Board Seat Contact Info
André Kerisit Chief Executive Officer, President & Chairman
You’re viewing 1 of 3 executive team members. Get the full list »

I.Ceram Board Members (1)

Name Representing Role Since
0000é 0000000 I.Ceram Chief Executive Officer, President & Chairman 000 0000
To view I.Ceram’s complete board members history, request access »

I.Ceram Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

I.Ceram Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore I.Ceram‘s full profile, request access.

Request a free trial

I.Ceram Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 14-Mar-2018 000000000 Surgical Devices
To view I.Ceram’s complete investments history, request access »